These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Pinder RM, Brogden RN, Speight TM, Avery GS. Drugs; 1977 Feb; 13(2):81-123. PubMed ID: 402258 [Abstract] [Full Text] [Related]
23. The use of clonazepam as an anticonvulsant--clinical evaluation. Bladin PF. Med J Aust; 1973 Apr 07; 1(14):683-8. PubMed ID: 4633863 [No Abstract] [Full Text] [Related]
25. [On the combination treatment of epileptic attacks]. Roth G. Wien Med Wochenschr; 1968 Feb 10; 118(6):116-8. PubMed ID: 4970152 [No Abstract] [Full Text] [Related]
27. Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Simon D, Penry JK. Epilepsia; 1975 Nov 10; 16(4):549-73. PubMed ID: 812693 [Abstract] [Full Text] [Related]
30. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA. Pediatrics; 2006 Aug 10; 118(2):e371-8. PubMed ID: 16847080 [Abstract] [Full Text] [Related]
31. Case summary: Benjamin. Rittey CD. Seizure; 1994 Dec 10; 3 Suppl A():25-7. PubMed ID: 7894847 [Abstract] [Full Text] [Related]
32. [Treatment of epilepsy]. Iivanainen M. Duodecim; 1974 Dec 10; 90(21):1414-48. PubMed ID: 4217271 [No Abstract] [Full Text] [Related]
33. Treatment of epilepsy. Ojemann LM, Ojemann GA. Am Fam Physician; 1984 Aug 10; 30(2):113-28. PubMed ID: 6431790 [Abstract] [Full Text] [Related]
34. [Treatment of status epilepticus with Rivotril]. Ketz E. Schweiz Med Wochenschr; 1973 Aug 11; 103(32):1134-8. PubMed ID: 4201955 [No Abstract] [Full Text] [Related]
35. Treatment of pediatric epilepsy: European expert opinion, 2007. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Epileptic Disord; 2007 Dec 11; 9(4):353-412. PubMed ID: 18077226 [Abstract] [Full Text] [Related]
36. [Results obtained with Depakine in epilepsy resistant to other therapies. Preliminary note]. Dumon-Radermecker M. Acta Neurol Psychiatr Belg; 1969 Nov 11; 69(11):901-8. PubMed ID: 4994423 [No Abstract] [Full Text] [Related]
37. [Clinical trial od Di-n-propylacetate in epileptics with therapy-resistant absences]. Lüdemann G, Cammann R-J, Knaape H-H. Psychiatr Neurol Med Psychol (Leipz); 1975 Feb 11; 27(2):101-7. PubMed ID: 812129 [Abstract] [Full Text] [Related]
38. Absences in juvenile myoclonic epilepsy: a clinical and video-electroencephalographic study. Panayiotopoulos CP, Obeid T, Waheed G. Ann Neurol; 1989 Apr 11; 25(4):391-7. PubMed ID: 2496640 [Abstract] [Full Text] [Related]
39. Lamotrigine in absence and primary generalized epilepsies. Mikati MA, Holmes GL. J Child Neurol; 1997 Nov 11; 12 Suppl 1():S29-37. PubMed ID: 9429128 [Abstract] [Full Text] [Related]
40. [Experimental and clinical results of a new anti-epileptic: sodium di-n-propyl acetate (DPA) specialized under the marketed name, Depakine. Second study]. de Biolley D, Sorel L. Acta Neurol Psychiatr Belg; 1969 Nov 11; 69(11):914-8. PubMed ID: 4994425 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]